Sharda Cropchem Ltd Set to Approve Q2 FY27 Results October 30

Sharda Cropchem Ltd is scheduled to consider unaudited standalone and consolidated financial results for Q2 FY27 and the half-year ended September 30, 2026, on October 30. The meeting follows Q1 FY27 revenue of ₹1,073.77 crore, a 9.03% year-on-year increase, while net profit declined 38.36% year-on-year to ₹88.02 crore.

What will Sharda Cropchem consider at its October 30 board meeting?

Sharda Cropchem will consider, approve and take on record unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The company informed BSE that its Board of Directors would meet on October 30, 2026, for this purpose.

The filing concerns Q2 FY27 results and the first half of FY27. It does not disclose the financial outcome ahead of the meeting. The company has also stated that the trading window for insiders will remain closed until November 2, 2026.

The results will provide the next reported update after the company's Q1 FY27 performance. Along with revenue and profitability, investors will be able to assess whether the trends described by management in the prior quarter continued through the September quarter.

How did Sharda Cropchem perform in Q1 FY27?

Sharda Cropchem reported Q1 FY27 revenue of ₹1,073.77 crore, up 9.03% from the corresponding quarter of the previous year but down 48.00% sequentially from ₹2,064.90 crore. The reported quarter was announced on July 29, 2026.

Profit before tax was ₹118.43 crore, compared with ₹422.08 crore in the preceding quarter, representing a 71.94% quarter-on-quarter decline. Net profit stood at ₹88.02 crore, down 72.38% sequentially from ₹318.72 crore and 38.36% lower year-on-year.

The company also reported EBITDA of ₹178 crore in Q1 FY27, up 25% year-on-year. Gross margin was reported at 36.7%. These measures indicate that the quarterly revenue increase did not translate into year-on-year growth in reported net profit.

What guidance has Sharda Cropchem provided for FY27?

Sharda Cropchem has reaffirmed FY27 revenue growth guidance of 10% to 15% and an EBITDA margin target of 18% to 20%. Management cited regional volume growth in Europe, NAFTA and Latin America as drivers supporting this outlook.

The guidance is relevant because the Q2 results will be the first half-year update after the company restated those targets. The October 30 disclosures may provide further information on the reported performance for the September quarter and the half-year, though the pre-meeting filing does not provide revised guidance.

Sharda Cropchem said its Q1 performance reflected sustained regional demand and operational efficiency. The company also stated that its board approved the unaudited financial statements and accepted B S R & Co. LLP's review report for the earlier reporting period.

How could the Q2 results matter to investors and industry participants?

The Q2 results matter because they will update investors on whether Sharda Cropchem's reported revenue growth and margin guidance are being maintained during FY27. Revenue, net profit, EBITDA and management commentary will be key disclosed measures for evaluating the September-quarter performance against the company's stated targets.

The available information does not provide a share-price movement, consensus estimate or a numerical market reaction linked to the upcoming results. Therefore, no conclusion can be drawn from the filing on how the market will respond before the financial statements are released.

For industry participants, management's earlier comments identified demand in Europe, NAFTA and Latin America as important operating factors. The Q2 release may clarify the contribution of these regions to volumes and financial performance, if the company provides such details with its results.

When will Sharda Cropchem discuss its Q2 FY27 earnings?

Sharda Cropchem has scheduled a conference call for November 2, 2026, at 3:00 PM IST to discuss Q2 FY27 earnings. Analysts and investors can join through the dial-in or web link announced by the company.

Senior management, including the Chairman, Chief Financial Officer and Company Secretary, are expected to participate. The call is scheduled after the board meeting and will offer a forum for management to discuss the quarterly results and outlook.

Conclusion

Sharda Cropchem's October 30 board meeting is the immediate disclosure event for investors, covering unaudited Q2 FY27 and first-half results. The company enters the announcement after Q1 revenue grew 9.03% year-on-year to ₹1,073.77 crore, while net profit declined 38.36% year-on-year to ₹88.02 crore.

The next scheduled event is the November 2 earnings call, when management is expected to discuss Q2 FY27 performance and its FY27 guidance of 10% to 15% revenue growth and EBITDA margins of 18% to 20%. Investors will watch for any update to those targets and for details on regional demand trends.